Quick Comparison

NMN (Nicotinamide Mononucleotide)Taurine
Half-Life2-3 minutes in blood (rapidly converted to NAD+). NAD+ half-life: 1-2 hours in tissue1-2 hours (plasma), but brain levels persist longer
Typical DosageStandard: 250-1000 mg daily. Sublingual may improve bioavailability by bypassing first-pass metabolism. Take in the morning — NAD+ follows circadian rhythm and morning supplementation aligns with natural peaks. Effects build over weeks.Standard: 500-2000 mg daily. Anti-aging research (animal-equivalent): 1000-3000 mg daily. Can be taken at any time of day.
AdministrationOral (capsules, powder, sublingual). Sublingual may improve bioavailability. Store in cool, dry place.Oral (capsules, powder, present in energy drinks at subtherapeutic doses).
Research Papers10 papers10 papers
Categories

Mechanism of Action

NMN (Nicotinamide Mononucleotide)

NMN is transported into cells via the Slc12a8 transporter (highly expressed in the small intestine and brain) and converted to NAD+ by nicotinamide mononucleotide adenylyltransferases (NMNAT1 in the nucleus, NMNAT2 in axons/Golgi, NMNAT3 in mitochondria). Elevated NAD+ activates the sirtuin family of NAD+-dependent protein deacetylases: SIRT1 deacetylates PGC-1alpha to promote mitochondrial biogenesis, SIRT3 activates superoxide dismutase 2 (SOD2) and isocitrate dehydrogenase 2 (IDH2) for mitochondrial antioxidant defense, and SIRT6 promotes base excision repair of oxidative DNA damage. NAD+ is also consumed by poly(ADP-ribose) polymerases (PARP1/2) during DNA repair — age-related NAD+ depletion impairs PARP function, allowing DNA damage accumulation. In neurons, NAD+ is required for glycolysis (GAPDH cofactor), the TCA cycle, and Complex I of the electron transport chain, directly fueling the enormous ATP demands of synaptic transmission. NAD+ decline with aging (approximately 50% reduction between ages 40-60) reduces all of these processes simultaneously, creating a cascade of mitochondrial dysfunction, impaired DNA repair, and neuroinflammation that NMN supplementation aims to reverse.

Taurine

Taurine activates GABA-A receptors (particularly extrasynaptic δ-containing subtypes) and glycine receptors (GlyR) as a partial agonist, providing inhibitory modulation that reduces neural excitability and hyperexcitability. It acts as a powerful antioxidant, scavenging hypochlorous acid, hydroxyl radicals, and peroxynitrite in mitochondria and cytosol. Taurine regulates calcium homeostasis via modulation of ryanodine receptors and IP3 receptors, preventing excitotoxic calcium overload. It modulates osmotic balance through the taurine transporter (TauT/SLC6A6) to protect cells from swelling under stress. Taurine may enhance mitochondrial function and biogenesis. Recent research shows it maintains telomere length, reduces cellular senescence markers (p16, p21), and modulates the mTOR pathway.

Risks & Safety

NMN (Nicotinamide Mononucleotide)

Common

Mild flushing, nausea, headache initially.

Serious

Long-term human safety data still limited (first human trials completed 2020-2023). Theoretical concern about promoting cancer growth in existing tumors (NAD+ fuels fast-growing cells).

Rare

Insomnia if taken late.

Taurine

Common

Very few — taurine has an excellent safety profile. Mild digestive discomfort at very high doses.

Serious

None documented at standard supplemental doses. Safe up to 6000 mg daily in studies.

Rare

Drowsiness, lowered blood pressure.

Full Profiles